Trade Summary

4 months ago, Bjork Elisabeth, serving as Dir at Rocket Pharmaceuticals, Inc. (RCKT), purchased 10,000 shares at $3.44 per share, for a total transaction value of $34,400.00. Following this transaction, Bjork Elisabeth now holds 50,000 shares of RCKT.

This purchase represents a 25.00% increase in Bjork Elisabeth's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, January 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, January 6, 2026 at 4:05 PM ET, 4 days after the trade was made.

Rocket Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.